August 2020

Components of mRNA Technology “Could Lead to Significant Adverse Events in One or More of Our Clinical Trials,” says Moderna

Components of mRNA Technology “Could Lead to Significant Adverse Events in One or More of Our Clinical Trials,” says Moderna By the Children’s Health Defense Team © August 6, 2020 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up

Components of mRNA Technology “Could Lead to Significant Adverse Events in One or More of Our Clinical Trials,” says Moderna Read More »

IS MRNA VACCINATION APPROACH SANE IN POST-COVID-19 ERA?

IS mRNA VACCINATION APPROACH SANE IN POST-COVID-19 ERA? On August 4, 2020, immunologist Dr. Tetyana Obukhanych posted her concerns about the COVID-19 mRNA vaccine candidate after reviewing recently published data.  She concludes that: ” … with serious gaps in published vaccine assessment, Moderna’s mRNA-1273 vaccine will likely fall short of delivering the long-awaited safe and

IS MRNA VACCINATION APPROACH SANE IN POST-COVID-19 ERA? Read More »